COMPOUNDS / AMINO ACID / PHENYLALANINE
AMINO ACID

PHENYLALANINE

LOW RISK
BEST FOR:Mood●●●●○○○○○○4/10
PHENYLALANINE · L-PHENYLALANINE · DL-PHENYLALANINE · DLPA · PHE · F · Β-PHENYLALANINE
Amino AcidCatecholamine PrecursorDietary SupplementMoodEssential Amino Acid

Essential amino acid and precursor to tyrosine, dopamine, norepinephrine, and phenylethylamine; used as a dietary supplement for mood and cognition.

ROUTE / DOSAGE
LOW500mg
STANDARD1000-1500mg
HIGH3000mg+
Note: Take on an empty stomach for better absorption; avoid late evening dosing
CYCLE
Daily use acceptable cycle 2 weeks on / 1 week off for chronic supplementation
BIOAVAILABILITY
~50-70% oral
ACTIVE DURATION
2-4h (subjective)
STORAGE
Room temperature dry away from light keep container tightly sealed
HALF-LIFE
1-2h (plasma)
DURATION BREAKDOWN
Total3-5h
Onset30-60 min
Come up30-45 min
Peak1-2h
Offset1-2h
After effects1-3h
Duration varies by route, dose, and individual. Source: community reports.
§ 01 — EFFECTS
5 documented
Mild mood elevation
Increased alertness
Catecholamine precursor support
Potential mild analgesia (DLPA)
Appetite modulation
§ 02 — RISKS
Dangerous for individuals with phenylketonuria (PKU) — causes severe neurotoxicity and brain damage
Hypertensive crisis when combined with MAO inhibitors due to catecholamine surge
Anxiety, jitteriness, and insomnia at high doses
Elevated blood pressure in susceptible individuals
Potential neurotoxicity from phenylalanine metabolites (phenylpyruvate, phenylacetate) when metabolism is impaired
§ 03 — INTERACTIONS
Interaction data not yet available for this compound.
§ 04 — SCIENCE

Phenylalanine is well established as an essential amino acid and the metabolic precursor to tyrosine and subsequently catecholamines. Research on phenylalanine supplementation for mood and pain is limited but suggests modest benefit in some populations, particularly for mild depression when combined with other precursors. Elevated phenylalanine levels are neurotoxic, as demonstrated in phenylketonuria (PKU) where PAH deficiency causes intellectual disability and behavioral problems. Recent work links dysregulated phenylalanine catabolism to cardiac aging via cellular senescence pathways. Evidence for cognitive enhancement in healthy individuals is weak and largely anecdotal.

§ 06 — SOURCES
[1]
Dysregulated Phenylalanine Catabolism Plays a Key Role in the Trajectory of Cardiac Aging
pubmed.ncbi.nlm.nih.gov ↗
[2]
Nutrition in phenylketonuria
pubmed.ncbi.nlm.nih.gov ↗
[3]
The phenylalanine hydroxylating system
pubmed.ncbi.nlm.nih.gov ↗
[4]
Phenylalanine metabolites in hyperphenylalaninemic children
pubmed.ncbi.nlm.nih.gov ↗
[5]
Fluctuations in phenylalanine concentrations in phenylketonuria
pubmed.ncbi.nlm.nih.gov ↗
[6]
Phenylalanine hydroxylase in melanoma cells
pubmed.ncbi.nlm.nih.gov ↗
[7]
Current Landscape on Development of Phenylalanine and Toxicity of its Metabolites
pubmed.ncbi.nlm.nih.gov ↗
[8]
Phenylalanine hydroxylation cofactor in phenylketonuria
pubmed.ncbi.nlm.nih.gov ↗
Disclaimer. Protokol.wiki is an informational reference. Nothing on this site is medical advice. Compounds listed may be unapproved, unregulated, or illegal in your jurisdiction. Consult a licensed physician before use. Data compiled from peer-reviewed literature.
METHODOLOGYCONTRIBUTECONTACT